Download PDF
Exp Clin Endocrinol Diabetes 2016; 124(02): 82-86
DOI: 10.1055/s-0035-1564200
Article
© Georg Thieme Verlag KG Stuttgart · New York

High Prolidase Levels may be a Marker of Irreversible Extracellular Matrix Changes in Controlled Acromegaly Patients?

S. Tabur
1   Gaziantep University, Gaziantep, Turkey
,
H. Sezen
2   Faculty of Medicine, Harran University, Sanliurfa, Turkey
,
H. Korkmaz
3   Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
,
M. Ozkaya
3   Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
,
E. Akarsu
3   Faculty of Medicine, Gaziantep University, Gaziantep, Turkey
› Author Affiliations
Further Information

Publication History

received 26 July 2015
first decision 07 September 2015

accepted 21 September 2015

Publication Date:
17 November 2015 (online)

Also available at
    Permissions and Reprints

Abstract

The present study aimed to evaluate the activity of prolidase in controlled acromegaly patients and its association with oxidative stress. 25 acromegalic patients in remission who were followed in our outpatient clinic and 31 healthy controls were enrolled in the study. Serum growth hormone (GH), insulin-like growth factor 1 (IGF-1), total antioxidative status (TAS), total oxidative stress (TOS), total free sulfhydryl (-SH), paraoxonase (PON), arylesterase (ARE), lipid hydroperoxide (LOOH) and prolidase activity levels were measured. Percent ratio of TOS to TAS level was accepted as oxidative stress index (OSI). Serum prolidase activity, TOS, OSI, and LOOH levels were significantly higher in acromegaly patients compared to the healthy control group (p<0.001, p=0.001, p<0.001, and p<0.001, respectively). SH levels were significantly lower in the acromegaly patients compared to the healthy control group (p=0.002). Prolidase activity were positively correlated with TOS, OSI, LOOH and negatively correlated with -SH in patients with acromegaly (r=0.471, p<0.001; r=0.527, p<0.001; r=0.717, p<0.001; r=− 0.516, p<0.001, respectively). These associations were confirmed in the multiple regression analysis (R2=0.502, p<0.001). In conclusion, serum prolidase activity and oxidative stress levels were high in controlled acromegaly patients. These results suggest that extracellular matrix changes continue eventhough the disease is controlled, and elevated oxidative stress is involved in the increased prolidase activity in acromegaly patients.

Key words

acromegaly - extracellular matrix - prolidase - oxidative status
 

  • References

  • 1 Valkusz Z, Tóth M, Boda J et al. The importance of early diagnosis in acromegaly. Orv Hetil 2011; 152: 696-702
    CrossrefPubMedGoogle Scholar
  • 2 Wassenaar MJ, Cazemier M, Biermasz NR et al. Acromegaly is associated with an increased prevalence of colonic diverticula: a case-control study. J Clin Endocrinol Metab 2010; 95: 2073-2079
    CrossrefPubMedGoogle Scholar
  • 3 van der Klaauw AA, Bax JJ, Smit JW et al. Increased aortic root diameters in patients with acromegaly. Eur J Endocrinol 2008; 159: 97-103
    CrossrefPubMedGoogle Scholar
  • 4 Antoniazzi F, Monti E, Venturi G et al. GH in combination with bisphosphonate treatment in osteogenesis imperfecta. Eur J Endocrinol 2010; 163: 479-487
    CrossrefPubMedGoogle Scholar
  • 5 Doessing S, Heinemeier KM, Holm L et al. Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis. J Physiol 2010; 588: 341-351
    CrossrefPubMedGoogle Scholar
  • 6 Hansen M, Boesen A, Holm L et al. Local administration of insulinlike growth factor-I (IGF-I) stimulates tendon collagen synthesis in humans. Scand J Med Sci Sports 2013; 23: 614-619
    PubMedGoogle Scholar
  • 7 Vestergaard PF, Jorgensen JOL, Olesen JL et al. Local Administration of Growth Hormone Stimulates Tendon Collagen Synthesis in Elderly Men. J Appl Physiol 2012; 113: 1432-1438
    CrossrefPubMedGoogle Scholar
  • 8 Horoz M, Aslan M, Bolukbas FF et al. Serum prolidase enzyme activity and its relation to histopathological findings in patients with non-alcoholic steatohepatitis. J Clin Lab Anal 2010; 24: 207-211
    CrossrefPubMedGoogle Scholar
  • 9 Cechowska-Pasko M, Pałka J, Wojtukiewicz MZ. Enhanced prolidase activity and decreased collagen content in breast cancer tissue. Int J Exp Pathol 2006; 87: 289-296
    CrossrefPubMedGoogle Scholar
  • 10 Nishizawa H, Handayaningsih AE, Iguchi G et al. Enhanced oxidative stress in GH-transgenic rat and acromegaly in humans. Growth Horm IGF Res 2012; 22: 64-68
    CrossrefPubMedGoogle Scholar
  • 11 Tabur S, Aksoy SN, Korkmaz H et al. Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma. Tumour Biol 2014; DOI: 10.1007/s13277-014-2889-6.
    PubMedGoogle Scholar
  • 12 Uzar E, Tamam Y, Evliyaoglu O et al. Serum prolidase activity and oxidative status in patients with diabetic neuropathy. Neurological Sciences 2012; 33: 875-880
    CrossrefPubMedGoogle Scholar
  • 13 Myara I, Myara A, Mangeot M et al. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clinical Chemistry 1984; 30: 211-215
    PubMedGoogle Scholar
  • 14 Erbagci AB, Araz M, Erbağci A et al. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clinical Biochemistry 2002; 35: 263-268
    CrossrefPubMedGoogle Scholar
  • 15 Savas M, Yeni E, Celik H et al. The association of serum prolidase activity and erectile dysfunction. Journal of Andrology 2010; 31: 146-154
    CrossrefPubMedGoogle Scholar
  • 16 Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: Application to imminodipeptiduria. Clin Chim Acta 1982; 125: 193-205
    CrossrefPubMedGoogle Scholar
  • 17 Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem 1952; 199: 91-95
    PubMedGoogle Scholar
  • 18 Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry 2004; 37: 112-119
    CrossrefPubMedGoogle Scholar
  • 19 Erel O. A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 2005; 38: 1103-1111
    CrossrefPubMedGoogle Scholar
  • 20 Aycicek A, Erel O, Kocyigit A. Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr Int 2005; 47: 635-639
    CrossrefPubMedGoogle Scholar
  • 21 Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77
    CrossrefPubMedGoogle Scholar
  • 22 Arab K, Steghens JP. Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem 2004; 325: 158-163
    CrossrefPubMedGoogle Scholar
  • 23 Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126-1138
    PubMedGoogle Scholar
  • 24 Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992; 30: 391-395
    PubMedGoogle Scholar
  • 25 Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839
    CrossrefPubMedGoogle Scholar
  • 26 Zitka O, Kukacka J, Krizkova S et al. Matrix metalloproteinases. Curr Med Chem 2010; 17: 3751-3768
    CrossrefPubMedGoogle Scholar
  • 27 Doessing S, Holm L, Heinemeier KM et al. and IGF1 levels are positively associated with musculotendinous collagen expression: experiments in acromegalic and GH deficiency patients. Eur J Endocrinol 2010; 163: 853-862
    CrossrefPubMedGoogle Scholar
  • 28 Thompson BJ, Shan CA, Waters MJ. Identification of genes induced by growht hormone in rat live using cDNA arrays. Endocrinology 2000; 141: 4321-4324
    CrossrefPubMedGoogle Scholar
  • 29 Quatresooz P, Hermanns-Lê T, Ciccarelli A et al. Tensegrity and type 1 dermal dendrocytes in acromegaly. Eur J Clin Invest 2005; 35: 133-139
    CrossrefPubMedGoogle Scholar
  • 30 Celik O, Akhan SE, Hatipoglu E et al. Increased incidence of pelvic organ prolapse in women with acromegaly. Eur J Obstet Gynecol Reprod Biol 2014; 183: 44-47
    CrossrefPubMedGoogle Scholar
  • 31 Karna E, Pałka J, Wołczyński S. Doxycycline-induced inhibition of prolidase activity in human skin fibroblasts and its involvement in impaired collagen biosynthesis. Eur J Pharmacol 2001; 430: 25-31
    CrossrefPubMedGoogle Scholar
  • 32 Panahi Y, Alishiri GH, Parvin S et al. Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial. J Diet Suppl 2015; DOI: 10.3109/19390211.2015.1008611.
    PubMedGoogle Scholar
  • 33 Claessen KM, Ramautar SR, Pereira AM et al. Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study. Eur J Endocrinol 2012; 167: 235-244
    PubMedGoogle Scholar
  • 34 Claessen KM, Ramautar SR, Pereira AM et al. Increased clinical symptoms of acromegalic arthropathy in patients with long-term disease control: a prospective follow-up study. Pituitary 2014; 17: 44-52
    CrossrefPubMedGoogle Scholar
  • 35 Kropf LL, Madeira M, Vieira Neto L et al. Functional evaluation of the joints in acromegalic patients and associated factors. Clin Rheumatol 2013; 32: 991-998
    CrossrefPubMedGoogle Scholar
  • 36 Anagnostis P, Efstathiadou ZA, Gougoura S et al. Oxidative stress and reduced antioxidative status, along with endothelial dysfunction inacromegaly. Horm Metab Res 2013; 45: 314-318
    Google Scholar